WINDLAS — Windlas Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Windlas Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	545	1,787	1,320	2,045	2,395
Net Total Accounts Receivable
Net Total Receivables	835	1,171	1,174	1,377	2,011
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,943	3,817	3,535	4,313	5,251
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	955	983	1,227	1,803	2,219
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,961	4,910	5,290	6,262	7,605
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	934	940	1,212	1,717	2,494
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	970	962	1,267	1,763	2,547
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	1,991	3,948	4,023	4,499	5,058
Total Liabilities & Shareholders' Equity	2,961	4,910	5,290	6,262	7,605
Total Common Shares Outstanding